Recent developments at Medical Marijuana, Inc. prompted the investor news organization to highlight MJNA’s stock for the second time in less than three weeks.
A review of Medical Marijuana, Inc.’s stock was published on Insider Financial for the second time in three weeks. Spotlighting what it describes as a recent “uptick in prices,” the investing news organization doubled down on its claim of a continued upward trend in share price.
Insider Financial provides insights and news for knowledgeable investors looking for guidance on how best to execute possible public and private capital allocation decisions.
After first pointing out the rise in MJNA’s market valuation from just above $180 million to around $305 million, the article then spotlights several of MJNA’s recent announcements.
Among the announcements highlighted in the article was the news out of Brazil, in which a Federal judge there ordered the government to subsidize payments for (Real Scientific Hemp Oil™ (RSHO™) CBD hemp oil for a Brazilian citizen.
The article also spotlights MJNA’s new Subscribe & Save program, which allows customers to receive automatic monthly shipments of their favorite CBD products at a 20% discount.
Altogether, the developments prompted the news organization up the ante on its previous bullish advice on MJNA and to conclude that MJNA is “poised for success.”
You can read the full Insider Financial article HERE.
Learn more about Medical Marijuana, Inc. and its portfolio of companies on our news feed.
